cva geriatric - Nursing Case Study

Pathophysiology

• Primary mechanism: Ischemic stroke occurs when a blood clot obstructs a cerebral artery, leading to reduced blood flow and oxygen delivery to brain tissue. This results in neuronal injury and cell death, particularly in areas most reliant on constant perfusion.

• Secondary mechanism: Hemorrhagic stroke involves the rupture of a blood vessel in the brain, causing bleeding and increased intracranial pressure. This compression of brain structures further compromises blood supply and exacerbates neuronal damage.

• Key complication: Both types of stroke can lead to significant neurological deficits, such as motor impairment, speech difficulties, and cognitive dysfunction, impacting quality of life and requiring comprehensive rehabilitation.

Patient Profile

Demographics:

78, female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Atrial Fibrillation

• Current medications: Lisinopril, Metformin, Warfarin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden weakness on the right side of the body and slurred speech

• Key symptoms: Partial loss of movement in the right arm and leg, difficulty speaking, mild headache, dizziness

• Vital signs: Blood pressure 158/92 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.4°F, oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

As the healthcare team continues to assess the 78-year-old patient, they focus on obtaining immediate diagnostic results to confirm the type of stroke and tailor the treatment plan accordingly. An urgent CT scan of the brain reveals an area of ischemia in the left middle cerebral artery territory, confirming an ischemic stroke. This finding correlates with her right-sided weakness and speech difficulties. Laboratory tests show an elevated blood glucose level of 230 mg/dL, indicating poor glycemic control, which could further complicate her recovery. Her INR is 1.8, below the therapeutic range for someone on warfarin with atrial fibrillation, suggesting inadequate anticoagulation management, possibly contributing to the stroke.

In addition, an ECG is performed to assess her cardiac rhythm due to a history of atrial fibrillation. The results show episodes of intermittent atrial fibrillation with a rapid ventricular response, which could have contributed to the formation of an embolus leading to the ischemic event. These findings prompt the healthcare team to adjust her anticoagulation therapy to better manage her atrial fibrillation and prevent future thromboembolic events.

The team now faces the challenge of balancing anticoagulation to prevent additional strokes while addressing the patient's elevated blood pressure and blood glucose levels. This requires close monitoring and potential adjustments to her medication regimen. The immediate focus is on stabilizing her condition and preventing the development of further complications, such as hemorrhagic transformation of the ischemic stroke or worsening of her diabetic control. This diagnostic information provides a clearer picture of the underlying issues and guides the next steps in her treatment and management plan.

Section 2

Following the adjustments in her anticoagulation therapy and management of her elevated blood glucose levels, the patient's condition initially appears to stabilize. However, 48 hours into her hospital stay, the healthcare team notes a change in her neurological status. The patient becomes increasingly lethargic and exhibits a sudden onset of confusion, disorientation to time and place, and a noticeable decline in her ability to follow simple commands. These changes raise concerns about potential complications, prompting an immediate re-evaluation of her condition.

A repeat CT scan is ordered and reveals a small area of hemorrhagic transformation in the region of the initial ischemic stroke. This finding is significant as it suggests that despite careful anticoagulation management, there has been a bleed into the ischemic area. Her vital signs show a slightly elevated blood pressure at 150/95 mmHg, which could exacerbate the risk of further hemorrhage. Her blood glucose remains elevated at 200 mg/dL, indicating ongoing issues with glycemic control. The INR is now at 2.5, which is within the therapeutic range, but the recent hemorrhagic transformation necessitates a careful reassessment of her anticoagulation regimen.

The healthcare team faces the critical task of balancing her anticoagulation therapy to prevent additional ischemic events while minimizing the risk of further hemorrhagic complications. The plan may involve temporarily pausing her anticoagulation treatment and introducing alternative strategies to manage her atrial fibrillation and stroke risk. Additionally, the team must address her blood pressure and glucose levels with more aggressive medical management, including potential adjustments to her antihypertensive and antidiabetic medications. Continuous monitoring and interdisciplinary collaboration will be essential to navigate these complexities and optimize her recovery while preventing additional complications.

Section 3

As the healthcare team navigates the delicate balance of managing the patient's anticoagulation therapy, they decide to temporarily hold her anticoagulant medication to address the risk of further hemorrhagic transformation. The team initiates a careful monitoring plan that includes frequent neurological assessments, vital signs monitoring, and close observation of her mental status. In addition, they consult with a cardiologist to evaluate alternative strategies for managing her atrial fibrillation, such as the possible use of a left atrial appendage closure device or short-term bridging with a lower-risk anticoagulant once the bleeding risk is mitigated.

Over the next 24 hours, close monitoring reveals that while the patient's neurological status remains stable, her blood pressure continues to be a concern, intermittently spiking to 160/100 mmHg despite being on antihypertensive medication. This prompts a re-evaluation of her antihypertensive regimen, and the healthcare team decides to add a calcium channel blocker to her current treatment plan. Concurrently, her blood glucose levels are addressed with an increased insulin regimen, aiming to maintain her glucose levels within a target range of 140-180 mg/dL to reduce the risk of further vascular complications.

Despite these interventions, the patient develops a new onset of mild aphasia and right-sided weakness, suggesting a potential extension of her initial ischemic event. A repeat neurological assessment and imaging confirm a slight progression of the infarcted area, necessitating a multidisciplinary approach involving neurology, cardiology, and endocrinology to fine-tune her management. The priority lies in stabilizing her hemodynamic status and optimizing her neurological recovery, while also preparing for eventual safe re-initiation of anticoagulation therapy to protect against further ischemic events. This complex scenario challenges the healthcare team to continually integrate and apply clinical reasoning to adapt the care plan in response to the evolving clinical picture.

Section 4

As the healthcare team continues to manage the patient’s multifaceted condition, they encounter a new complication: the patient develops acute kidney injury (AKI), likely secondary to the contrast used in recent imaging studies and the fluctuating blood pressure. Her serum creatinine has risen from 1.0 mg/dL to 2.1 mg/dL, and her estimated glomerular filtration rate (eGFR) has decreased, indicating impaired renal function. This development necessitates an immediate review and adjustment of her medication regimen, especially concerning nephrotoxic agents and those requiring renal dosing adjustments. The team decides to consult with a nephrologist to assess the extent of the renal impairment and to guide further management, including the possibility of temporary renal support or dialysis if her condition deteriorates.

In response to the AKI and to prevent further renal damage, the team intensifies the patient's fluid management strategy, ensuring adequate hydration while balancing her blood pressure control. They carefully monitor her fluid intake and output, as well as daily weights, to detect any signs of fluid overload or dehydration. Additionally, they reassess the use of certain antihypertensives that may exacerbate renal impairment, opting for agents with minimal renal metabolism. Meanwhile, her blood pressure remains labile, with occasional spikes despite these adjustments, prompting consideration of further diagnostic tests to rule out secondary causes of hypertension.

The patient’s overall status remains fragile, with her neurological deficits showing minimal improvement, reflecting the delicate interplay of her cardiovascular, renal, and neurological systems. This situation underscores the importance of vigilant monitoring and iterative care planning as the team strives to stabilize her condition. The healthcare team remains focused on the critical balance between preventing further ischemic events and managing the risk of hemorrhage, exemplified by their cautious approach to reinitiating anticoagulation therapy. This case continues to challenge the team’s clinical reasoning skills, as they must anticipate and respond to the evolving complexities of the patient’s condition.

Section 5

As the healthcare team continues their vigilant monitoring, they observe a new complication: the patient begins to exhibit signs of pulmonary congestion, evident by increased respiratory rate, moist crackles on auscultation, and mild peripheral edema. Her oxygen saturation has decreased to 88% on room air, necessitating supplemental oxygen to maintain adequate levels above 92%. A chest X-ray confirms mild pulmonary edema, likely secondary to fluid management challenges in the context of her acute kidney injury and labile blood pressure.

The team adjusts the fluid management strategy, cautiously reducing her fluid intake while administering diuretics to alleviate the pulmonary congestion, albeit with close monitoring to prevent further renal compromise. They also review her current medications, particularly those that might contribute to fluid retention or exacerbate heart failure symptoms. Her blood pressure remains erratic, with systolic readings fluctuating between 160-180 mmHg, complicating the balance between controlling her hypertension and avoiding hypoperfusion of the kidneys.

In response to these developments, the nephrologist recommends the initiation of a low-dose loop diuretic regimen, suggesting careful titration based on her daily weights and urine output. The multidisciplinary team considers the possibility of a secondary cause for her labile blood pressure, such as renovascular disease or pheochromocytoma, and plans for further diagnostic testing once her condition stabilizes. This ongoing complexity challenges the team's clinical reasoning and underscores the necessity for a dynamic and individualized approach to her care plan, as they strive to prevent new complications while managing her existing conditions.